Xperi’s (XPER) “Buy” Rating Reiterated at BWS Financial

Дата публикации: 10-08-2026 05:30:51

BWS Financial reissued their buy rating on shares of Xperi (NYSE:XPER – Free Report) in a research report report published on Friday,Benzinga reports. BWS Financial currently has a $12.00 price target on the stock. XPER has been the subject of a number of other reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Piper Sandler Cuts Abacus Global Management (NYSE:ABX) Price Target to $12.00	0	10.81	10-08-2026
2	Innodata’s (INOD) “Top Pick” Rating Reiterated at BWS Financial	0	9.16	10-08-2026
3	BTIG Research Cuts NRx Pharmaceuticals (NASDAQ:NRXP) Price Target to $10.00	0	9.08	10-08-2026
4	NexPoint Real Estate Finance (NYSE:NREF) Price Target Raised to $17.50	0	10.14	10-08-2026
5	Teleflex’s (TFX) Overweight Rating Reiterated at Piper Sandler	0	10.31	10-08-2026
6	Twilio (NYSE:TWLO) Price Target Raised to $247.00	0	12.6	10-08-2026
7	Definium Therapeutics’ (DFTX) “Overweight” Rating Reiterated at Piper Sandler	0	8.75	10-08-2026
8	STERIS’s (STE) “Overweight” Rating Reiterated at Piper Sandler	0	9.98	10-08-2026
9	Doximity’s (DOCS) “Overweight” Rating Reiterated at Piper Sandler	0	9.98	10-08-2026
10	Arteris’ (AIP) “Buy” Rating Reiterated at Rosenblatt Securities	0	9.98	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.11. Источник: www.americanbankingnews.com.